Domov › Steatotična bolezen jeter › Texas › Houston

Klinične študije za Steatotična bolezen jeter v Houston, TX

13 študij za Steatotična bolezen jeter išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Vključevanje udeležencevFaza 3

89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston

Starost 18–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Vključevanje udeležencevFaza 3

89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston
in še 1

Starost 18–80 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Vključevanje udeležencevFaza 3

GSK Investigational Site, Houston
GSK Investigational Site, Bellaire · 7 mi stran
GSK Investigational Site, Humble · 17 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Vključevanje udeležencevFaza 3

GSK Investigational Site, Bellaire · 7 mi stran
GSK Investigational Site, Humble · 17 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07701993

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Vključevanje udeležencevFaza 2

Pioneer Research Solutions, Inc., Houston

Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Vključevanje udeležencevFaza 3

HRI- Medical Center, Houston
Care Access - Houston, Houston
Houston Research Institute, Houston
in še 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Vključevanje udeležencevFaza 3

Akero Clinical Study Site, Houston
Akero Clinical Study Site, Houston
Akero Clinical Study Site, Houston
in še 3

Starost 18–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Vključevanje udeležencevFaza 2

Houston Research Institute - Medical Center, Houston
Houston Research Institute, Houston
Bellaire Clinical Research, Bellaire · 7 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07288138

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Vključevanje udeležencevFaza 3

GSK Investigational Site, Houston
GSK Investigational Site, Bellaire · 7 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Vključevanje udeležencevFaza 2

GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Houston

Starost 18–75 · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci

Pioneer Research Solutions, Houston

Starost 18–75 · Vsi spoli · Posodobljeno 16. apr. 2026 · NCT05648214

NAFLD Clinical Care Pathway

Vključevanje udeležencevVabljeni zdravi prostovoljci

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 14. nov. 2025 · NCT06671886

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Vključevanje udeležencevOpazovalna študija

First Surgical Hospital, Bellaire · 7 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 14. avg. 2025 · NCT07122700

Študije za Steatotična bolezen jeter v drugih mestih

Druge študije v Houston

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.